LNJ3 Med

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

LNJ3 Med

Nandrin ·KBO/BCE: BE 0775.471.151

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility Decision tools Company map

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Developers Badge Business information compared Free company information

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Your question travels, with the dossier's public data, to our AI model at Anthropic in the US. Nothing that identifies you goes along, and we keep neither question nor answer. Answers can be wrong, so this is not legal advice. How it works

Year closed	Due by	Filed	Variance	Reference
31-03-2025	31-10-2025	29-10-2025	2 d early	2025-00551709
31-03-2024	31-10-2024	28-10-2024	3 d early	2024-00515655
31-03-2023	31-10-2023	06-10-2023	25 d early	2023-00473794
31-03-2022	31-10-2022	30-09-2022	31 d early	2022-20441760

Metric	This company	Sector median	Position in the sector
Solvency	83.9%	41.6%	better than 90% of 94 sector peers
Net result	€26k	€49k	better than 33% of 94 sector peers
Equity	€49k	€90k	better than 35% of 94 sector peers
Gross operating margin	€43k	€150k	better than 15% of 94 sector peers
Total assets	€58k	€409k	better than 5% of 94 sector peers

Fiscal year	2025
Deposit	volledig
Revenue	-
EBITDA	€42k
Net profit	€26k
Cash flow	€27k
Staff costs	-
Income taxes	€10k
Dividends	€30k
Total assets	€58k
Equity	€49k
Debt	€9k
of which ≤ 1y	€9k
of which > 1y	-
Working capital	€45k
Employees (FTE)	-

	2025
Current ratio	5.82
Quick ratio	5.82
Working capital ratio	77.5%
Solvency	83.9%
Debt / equity	0.19
Long-term debt ratio	-
Interest coverage	7.80
Gross margin	-
Net margin	-
ROA	44.7%
ROE	53.2%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€58k
Fixed assets	21/28	€4k
Tangible fixed assets	22/27	€4k
Current assets	29/58	€55k
Amounts receivable within one year	40/41	€6k
Cash & bank	54/58	€48k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€58k
Equity	10/15	€49k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€47k
Amounts payable	17/49	€9k
Amounts payable within one year	42/48	€9k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€43k
Operating result	9901	€41k
Financial income	75	€675
Financial charges	65	€5k
Result before taxes	9903	€37k
Income taxes	67/77	€10k
Net result for the period	9904	€26k
Result to be appropriated	9905	€26k

Summary

Conclusion

Signals

Filing behaviour

Trust signals

Administrative Flags

Bankruptcy probability (12 mo)

Financials

Annual accounts & ratios

Health barometer

Structure & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Publications

Lifecycle & Insolvency Signals

Belgisch Staatsblad · acts

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)